...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
【24h】

Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.

机译:作为胆碱酯酶和淀粉样β聚集的双重抑制剂的新型氧代异吗啡衍生物的合成和表征。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 3-substituted (5c-5f, 6c-6f) and 4-substituted (10a-10g) oxoisoaporphine derivatives were synthesized. It was found that all these synthetic compounds had IC50 values at micro or nano molar range for cholinesterase inhibition, and most of them could inhibit amyloid beta (Abeta) self-induced aggregation with inhibition ratio from 31.8% to 57.6%. The structure-activity relationship studies revealed that the derivatives with higher selectivity on AChE also showed better inhibition on Abeta self-induced aggregation. The results from cell toxicity study indicated that most quaternary methiodide salts had higher IC50 values than the corresponding non-quaternary compounds. This study provided potentially important information for further development of oxoisoaporphine derivatives as lead compounds for the treatment of Alzheimer's disease.
机译:合成了一系列的3个取代的(5c-5f,6c-6f)和4个取代的(10a-10g)氧代异吗啡衍生物。结果发现,所有这些合成化合物的胆碱酯酶抑制作用均在微米或纳摩尔范围内,且大多数可抑制淀粉样蛋白(Abeta)自诱导的聚集,抑制率在31.8%至57.6%之间。结构-活性关系研究表明,对AChE具有较高选择性的衍生物也显示出对Abeta自诱导聚集的更好抑制作用。细胞毒性研究的结果表明,大多数季铵盐具有比相应的非季铵盐化合物更高的IC50值。这项研究提供了潜在的重要信息,为进一步开发氧代异吗啡衍生物作为治疗阿尔茨海默氏病的先导化合物提供了可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号